Zelira in the news
For media related enquiries please contact Damien Carbon at Profile Media
Ph: +61 (0) 412 332 122 E: email@example.com
March 2019 Quarterly Report
The Board of Zelda Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF) is pleased to
provide this operational update with its Appendix 4C for the three-months to
31 March 2019.